Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Viability Assessment Using Flavin Mononucleotide (FMN) Measured in Perfusate and Bile During Normothermic Machine Perfusion: an International, Multi-center Validation Study

NCT07315204 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT07315204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07315204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Viability Assessment Using Flavin Mononucleotide (FMN) Measured in Perfusate and Bile During Normothermic Machine Perfusion: an International, Multi-center Validation Study
Lead sponsor
The Cleveland Clinic
Phase
Observational
Overall status
Recruiting
Start date
March 13, 2026
Completion date
December 31, 2028
Enrollment
850 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplant disorder